Biographical Sketch
Carol F. Farver, MD, is a Staff pathologist in the Department of Anatomic Pathology at Cleveland Clinic's main campus. She joined Cleveland Clinic in 1995 and also holds joint appointments for Cleveland Clinic’s Transplantation Center, and Departments of Pulmonary and Critical Care Medicine, Pathobiology and Education Division.
In addition to her medical degree from Yale University, she has two master’s degrees and attended the doctoral program at University of California at Berkeley. Dr. Farver served as chief resident at Brigham and Woman’s Hospital, Boston, and went on to be a clinical and research fellow as well as instructor at Harvard Medical School. She is now Assistant Clinical Professor of Medicine at Case Western Reserve University. She is licensed to practice medicine in both Ohio and Massachusetts, and is board-certified in anatomic pathology.
She has participated either as lead author or co-author in dozens of peer-reviewed journal articles and abstracts with her major research interests including cytokine control of lung injury, prognostic indicators of lung cancer and biology/pathology of lung transplantation. She is also a renowned speaker for educational and scientific sessions.
Dr. Farver has received the Cleveland Clinic’s Word Class Service Leadership Development Award, and the Innovator Award for a ‘Dual Frequency Ventilation' project. She is past president of the Cleveland Society of Pathologists, and current member of the American Society for Investigative Pathology, United States and Canadian Academy of Pathology, American Thoracic Society, American Society of Clinical Pathologists, Ohio Society of Pathologists and New England Society of Pathologists.
Industry Relationships
Cleveland Clinic physicians and scientists report if they
have any collaborations with the pharmaceutical or medical
device industries as part of the Cleveland Clinic’s
procedures. The Cleveland Clinic publicly discloses
payments to its physicians and scientists for speaking and
consulting of $5,000 or more per year, and any equity,
royalties, and fiduciary relationships in companies with
which they collaborate. In publicly disclosing this
information, the Cleveland Clinic tries to provide
information as accurately as possible about its doctors’
connections with industry and those of their immediate
family members. As of 9/4/2008,
Dr. Farver has reported no financial relationship with
industry that is applicable to this listing. Patients
should feel free to contact their doctor about
relationships with industry and how the relationships are
overseen by the Cleveland Clinic. To learn more about
the Cleveland Clinic’s policies on collaborations with
industry and innovation management, go to our
Integrity in Innovation page.
